Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct.

Front Pharmacol · 2023 · PMC10076569 · PMID 37033639

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, already normofiltrating control mice showed a trend towards kidney weight gain after EMPA treatment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.